Herpes simplex virus (HSV)-specific proliferative and cytotoxic T-cell responses in humans immunized with an HSV type 2 glycoprotein subunit vaccine.

Documenti analoghi

• Detection of asymptomatic initial herpes simplex virus (HSV) infections in animals immunized with subunit HSV glycoprotein vaccines.
  di: Bernstein, D I, et al.
  Pubblicazione: (1990)
• Humoral immune response to herpes simplex virus type 2 glycoproteins in patients receiving a glycoprotein subunit vaccine.
  di: Ashley, R, et al.
  Pubblicazione: (1985)
• Herpes simplex virus (HSV)-specific human T-cell clones recognize HSV glycoprotein D expressed by a recombinant vaccinia virus.
  di: Zarling, J M, et al.
  Pubblicazione: (1986)
• Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine
  di: Awasthi, Sita, et al.
  Pubblicazione: (2009)
• Trivalent Glycoprotein Subunit Vaccine Prevents Neonatal Herpes Simplex Virus Mortality and Morbidity
  di: Patel, Chaya D., et al.
  Pubblicazione: (2020)